vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Distribution Solutions Group, Inc. (DSGR). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $518.0M, roughly 1.6× Distribution Solutions Group, Inc.). Distribution Solutions Group, Inc. runs the higher net margin — 1.2% vs 0.5%, a 0.7% gap on every dollar of revenue. On growth, Distribution Solutions Group, Inc. posted the faster year-over-year revenue change (10.7% vs 7.5%). Over the past eight quarters, Distribution Solutions Group, Inc.'s revenue compounded faster (13.1% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
ACHC vs DSGR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $518.0M |
| Net Profit | $4.5M | $6.5M |
| Gross Margin | — | 32.9% |
| Operating Margin | — | 4.6% |
| Net Margin | 0.5% | 1.2% |
| Revenue YoY | 7.5% | 10.7% |
| Net Profit YoY | -50.8% | -70.6% |
| EPS (diluted) | $0.05 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $518.0M | ||
| Q2 25 | $869.2M | $502.4M | ||
| Q1 25 | $770.5M | $478.0M | ||
| Q4 24 | $774.2M | $480.5M | ||
| Q3 24 | $815.6M | $468.0M | ||
| Q2 24 | $796.0M | $439.5M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $6.5M | ||
| Q2 25 | $30.1M | $5.0M | ||
| Q1 25 | $8.4M | $3.3M | ||
| Q4 24 | $32.6M | $-25.9M | ||
| Q3 24 | $68.1M | $21.9M | ||
| Q2 24 | $78.5M | $1.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 33.9% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | — | 33.9% | ||
| Q2 24 | — | 34.5% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 4.6% | ||
| Q2 25 | 5.8% | 5.3% | ||
| Q1 25 | 1.7% | 4.2% | ||
| Q4 24 | 4.9% | 4.2% | ||
| Q3 24 | 12.1% | 4.0% | ||
| Q2 24 | 13.4% | 3.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | 1.2% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 1.1% | 0.7% | ||
| Q4 24 | 4.2% | -5.4% | ||
| Q3 24 | 8.4% | 4.7% | ||
| Q2 24 | 9.9% | 0.4% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $0.14 | ||
| Q2 25 | $0.33 | $0.11 | ||
| Q1 25 | $0.09 | $0.07 | ||
| Q4 24 | $0.36 | $-0.55 | ||
| Q3 24 | $0.74 | $0.46 | ||
| Q2 24 | $0.85 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $69.2M |
| Total DebtLower is stronger | $2.5B | $665.5M |
| Stockholders' EquityBook value | $2.0B | $653.9M |
| Total Assets | $5.5B | $1.8B |
| Debt / EquityLower = less leverage | 1.29× | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $69.2M | ||
| Q2 25 | $131.4M | $47.4M | ||
| Q1 25 | $91.2M | $65.4M | ||
| Q4 24 | $76.3M | $66.5M | ||
| Q3 24 | $82.1M | $61.3M | ||
| Q2 24 | $77.2M | $46.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $665.5M | ||
| Q2 25 | $2.3B | $675.0M | ||
| Q1 25 | $2.2B | $712.4M | ||
| Q4 24 | $2.0B | $693.9M | ||
| Q3 24 | $1.9B | $704.1M | ||
| Q2 24 | $1.8B | $573.7M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $653.9M | ||
| Q2 25 | $3.1B | $649.4M | ||
| Q1 25 | $3.0B | $636.7M | ||
| Q4 24 | $3.1B | $640.5M | ||
| Q3 24 | $3.0B | $680.8M | ||
| Q2 24 | $3.0B | $653.3M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $1.8B | ||
| Q2 25 | $6.3B | $1.8B | ||
| Q1 25 | $6.1B | $1.8B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $5.7B | $1.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 1.02× | ||
| Q2 25 | 0.74× | 1.04× | ||
| Q1 25 | 0.72× | 1.12× | ||
| Q4 24 | 0.64× | 1.08× | ||
| Q3 24 | 0.62× | 1.03× | ||
| Q2 24 | 0.62× | 0.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $38.4M |
| Free Cash FlowOCF − Capex | — | $32.9M |
| FCF MarginFCF / Revenue | — | 6.3% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | 13.78× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $92.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $38.4M | ||
| Q2 25 | $133.5M | $33.3M | ||
| Q1 25 | $11.5M | $-4.8M | ||
| Q4 24 | $116.7M | $45.7M | ||
| Q3 24 | $163.1M | $-17.3M | ||
| Q2 24 | $171.1M | $21.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $32.9M | ||
| Q2 25 | $-34.2M | $28.7M | ||
| Q1 25 | $-163.2M | $-10.4M | ||
| Q4 24 | $-86.8M | $41.1M | ||
| Q3 24 | $-27.1M | $-20.5M | ||
| Q2 24 | $16.9M | $18.0M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | 6.3% | ||
| Q2 25 | -3.9% | 5.7% | ||
| Q1 25 | -21.2% | -2.2% | ||
| Q4 24 | -11.2% | 8.6% | ||
| Q3 24 | -3.3% | -4.4% | ||
| Q2 24 | 2.1% | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 1.1% | ||
| Q2 25 | 19.3% | 0.9% | ||
| Q1 25 | 22.7% | 1.2% | ||
| Q4 24 | 26.3% | 1.0% | ||
| Q3 24 | 23.3% | 0.7% | ||
| Q2 24 | 19.4% | 0.8% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 5.95× | ||
| Q2 25 | 4.43× | 6.66× | ||
| Q1 25 | 1.37× | -1.46× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | -0.79× | ||
| Q2 24 | 2.18× | 11.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
